ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson

April 25, 2014

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

NCI 1985 Bypass Budget By Groups

May 20, 1983

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

November 25, 1983